They observed in T cells from RA patients that the hypermethylation of the promoter region of CTLA-4 prevented the binding of the nuclear factor of activated T cells (NF-AT) which decreased CTLA-4 expression resulting in a failure to activate the immunomodulatory kynurenine pathway of Treg cells. The gene discussed is CTLA4; the disease is rheumatoid arthritis.